Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP588218.RAZaxyL01qqdT3d0btZHn2IZDwgdH-Gzo6_JjMoErSYb0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP588218.RAZaxyL01qqdT3d0btZHn2IZDwgdH-Gzo6_JjMoErSYb0130_assertion type Assertion NP588218.RAZaxyL01qqdT3d0btZHn2IZDwgdH-Gzo6_JjMoErSYb0130_head.
- NP588218.RAZaxyL01qqdT3d0btZHn2IZDwgdH-Gzo6_JjMoErSYb0130_assertion description "[KRAS and BRAF mutations occur in colorectal cancers (CRCs) and are considered mutually exclusive methods of activating the RAS/RAF/MEK/ERK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP588218.RAZaxyL01qqdT3d0btZHn2IZDwgdH-Gzo6_JjMoErSYb0130_provenance.
- NP588218.RAZaxyL01qqdT3d0btZHn2IZDwgdH-Gzo6_JjMoErSYb0130_assertion evidence source_evidence_literature NP588218.RAZaxyL01qqdT3d0btZHn2IZDwgdH-Gzo6_JjMoErSYb0130_provenance.
- NP588218.RAZaxyL01qqdT3d0btZHn2IZDwgdH-Gzo6_JjMoErSYb0130_assertion SIO_000772 19474002 NP588218.RAZaxyL01qqdT3d0btZHn2IZDwgdH-Gzo6_JjMoErSYb0130_provenance.
- NP588218.RAZaxyL01qqdT3d0btZHn2IZDwgdH-Gzo6_JjMoErSYb0130_assertion wasDerivedFrom befree-20140225 NP588218.RAZaxyL01qqdT3d0btZHn2IZDwgdH-Gzo6_JjMoErSYb0130_provenance.
- NP588218.RAZaxyL01qqdT3d0btZHn2IZDwgdH-Gzo6_JjMoErSYb0130_assertion wasGeneratedBy ECO_0000203 NP588218.RAZaxyL01qqdT3d0btZHn2IZDwgdH-Gzo6_JjMoErSYb0130_provenance.